Table 3 ART and adverse event related characteristics of patients that were LTFU compared to those that remained in care, Tshepang Pharmacovigilance cohort, 2004-2012
Variable | Total | LTFU | In care | χ2 | ||||
|---|---|---|---|---|---|---|---|---|
N | % | n | (%) | n | % | p - value | ||
Initiating regimen | d4t containing* | 581 | 98.3 | 443 | 98.0 | 138 | 99.3 | 0.466 |
4missing | Other | 10 | 1.7 | 9 | 2.00 | 139 | 0.7 | |
Alcohol | No | 468 | 82.4 | 107 | 82.95 | 361 | 82.2 | 0.852 |
27 missing | Yes | 100 | 17.6 | 22 | 17.05 | 78 | 7.8 | |
Adverse events | No | 251 | 44.3 | 67 | 51.5 | 184 | 42.1 | 0.057 |
28 missing | Yes | 316 | 55.7 | 63 | 48.5 | 253 | 57.9 | |